Literature DB >> 16395714

Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin gamma-2 chain is an early coordinated event in incipient oral squamous cell carcinoma.

Pia Lindberg1, Ake Larsson, Boye Schnack Nielsen.   

Abstract

Cancer cell invasion is facilitated by extracellular matrix degrading proteases such as plasmin. We have studied the expression of plasminogen activator inhibitor-1 (PAI-1) and urokinase receptor (uPAR) together with the gamma2-chain of laminin-5 (lam-gamma2) by immunohistochemistry in 20 cases with incipient oral squamous cell carcinoma (SCC). PAI-1-positive neoplastic cells located at the tip of the putative invasive front of grade 1 (incipient) carcinoma were seen in 16 of the 20 cases (75%), whereas adjacent normal and dysplastic epithelium was PAI-1-negative. Clusters of putative invasive neoplastic cells located in the lamina propria were PAI-1-positive in areas with grade 2 incipient carcinoma as were invasive cancer cells in areas of grade 3-4 invasive carcinoma. uPAR immunoreactivity was strongly expressed in numerous stromal cells in the carcinoma area in all 20 lesions, while a few uPAR-positive stromal cells were found in areas with normal and dysplastic epithelium. uPAR-positive neoplastic cell islands located at the front of the lesions were seen in 15 of the 20 cases. The expression pattern of lam-gamma2 was very similar to that of PAI-1; however, lam-gamma2-positive neoplastic cells were only detected in 11 of the 20 cases (55%) in areas of grade 1 incipient carcinoma. Direct comparison of the 3 components revealed colocalization in neoplastic cell islands in both incipient and invasive SCC. Our results suggest that PAI-1 is a novel potential marker of initial invasion in oral SCC, and that the coordinated expression of PAI-1 with uPAR and lam-gamma2 sustain the features of the early invasive cancer cells. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395714     DOI: 10.1002/ijc.21568

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.

Authors:  Zonggao Shi; Yueying Liu; Jeffrey J Johnson; M Sharon Stack
Journal:  Mol Cell Biochem       Date:  2011-06-01       Impact factor: 3.396

2.  Contrary melanoma-associated antigen-A expression at the tumor front and center: A comparative analysis of stage I and IV head and neck squamous cell carcinoma.

Authors:  Stefan Hartmann; Muna Brisam; Stephan Rauthe; Oliver Driemel; Roman C Brands; Andreas Rosenwald; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

3.  Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.

Authors:  Supurna Ghosh; Jennifer Koblinski; Jeffrey Johnson; Yueying Liu; Aaron Ericsson; J Wade Davis; Zonggao Shi; Matthew J Ravosa; Susan Crawford; Shellaine Frazier; M Sharon Stack
Journal:  Mol Cancer Res       Date:  2010-02-09       Impact factor: 5.852

4.  PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.

Authors:  Jennifer Freytag; Cynthia E Wilkins-Port; Craig E Higgins; Stephen P Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  J Invest Dermatol       Date:  2010-04-29       Impact factor: 8.551

5.  ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.

Authors:  Gianluigi Mazzoccoli; Valerio Pazienza; Anna Panza; Maria Rosa Valvano; Giorgia Benegiamo; Manlio Vinciguerra; Angelo Andriulli; Ada Piepoli
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-24       Impact factor: 4.553

6.  Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells.

Authors:  Monica Lupu-Meiri; Elizabeth Geras-Raaka; Ruth Lupu; Hagit Shapira; Judith Sandbank; Liora Segal; Marvin C Gershengorn; Yoram Oron
Journal:  J Cell Physiol       Date:  2012-11       Impact factor: 6.384

7.  Gene expression profiling identifies genes predictive of oral squamous cell carcinoma.

Authors:  Chu Chen; Eduardo Méndez; John Houck; Wenhong Fan; Pawadee Lohavanichbutr; Dave Doody; Bevan Yueh; Neal D Futran; Melissa Upton; D Gregory Farwell; Stephen M Schwartz; Lue Ping Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-31       Impact factor: 4.254

8.  DNA Methylation Profiles of Protease Nexin 1 (SERPINE2) Gene in Human Cell Lines.

Authors:  Shan Gao; Peter A Andreasen
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

9.  Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity.

Authors:  Jason R Pettus; Jeffrey J Johnson; Zonggao Shi; J Wade Davis; Jennifer Koblinski; Supurna Ghosh; Yueying Liu; Matthew J Ravosa; Shellaine Frazier; M Sharon Stack
Journal:  Histol Histopathol       Date:  2009-02       Impact factor: 2.303

10.  Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.

Authors:  Raja R Seethala; William E Gooding; Phoebe N Handler; Bobby Collins; Qing Zhang; Jill M Siegfried; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.